InspireMD, Inc.
NSPRNASDAQHealthcare● Active
$0.82
$-0.06(-7.24%)
Market Cap$38234676
P/E Ratio—
52W High$2.93
52W Low$0.8
InspireMD, Inc. (NSPR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NSPR · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.98M | $7.01M | $6.21M | $5.17M | $4.50M |
| Cost of Revenue | $6.33M | $5.50M | $4.40M | $4.05M | $3.74M |
| Gross Profit | $2.65M | $1.51M | $1.81M | $1.12M | $0.75M |
| Gross Margin %(computed) | 29.50% | 21.49% | 29.12% | 21.60% | 16.77% |
| Operating Expenses | |||||
| R&D Expenses | $15.00M | $13.63M | $7.98M | $7.81M | $5.16M |
| G&A Expenses | $20.71M | $15.31M | $11.10M | $8.36M | $7.41M |
| Total Operating Expenses | $51.76M | $35.01M | $22.95M | $19.83M | $15.47M |
| Operating Income | ($49.11M) | ($33.50M) | ($21.14M) | ($18.71M) | ($14.72M) |
| Operating Margin %(computed) | -546.97% | -478.00% | -340.74% | -361.88% | -327.39% |
| Interest Income | $0.00M | $1.56M | $1.29M | $0.25M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.16M |
| Income Before Tax | ($48.72M) | ($31.95M) | ($19.85M) | ($18.46M) | ($14.87M) |
| Income Tax Expense | $0.06M | $0.06M | $0.07M | $0.03M | $0.04M |
| Net Income | ($48.79M) | ($32.01M) | ($19.92M) | ($18.49M) | ($14.92M) |
| Net Margin %(computed) | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.76 | $-0.76 | $-0.82 | $-2.35 | $-2.03 |
| Wtd Avg Shares | 73.47M | 41.93M | 24.27M | 7.87M | 7.35M |
| EBITDA | ($48.64M) | ($33.22M) | ($20.91M) | ($18.52M) | ($14.55M) |
| EBITDA Margin %(computed) | -541.66% | -474.00% | -337.00% | -358.25% | -323.80% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more InspireMD, Inc. data
About InspireMD, Inc. (NSPR) Income Statement
InspireMD, Inc. (NSPR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NSPR reported revenue of $0.01B, gross profit of $0.00B (gross margin 29.50%), and net income of ($0.05B) — a net profit margin of -543.33%.
Frequently asked questions
NSPR · 4 questionsInspireMD, Inc. (NSPR) reported revenue of $0.01B for 2025, up 28.1% year-over-year.
NSPR revenueNSPR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09